Open Access. Powered by Scholars. Published by Universities.®

Life Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

Neuroscience and Neurobiology

Virginia Commonwealth University

Series

Brain injury

Publication Year

Articles 1 - 2 of 2

Full-Text Articles in Life Sciences

Proteomics: In Pursuit Of Effective Traumatic Brain Injury Therapeutics, Pavel N. Lizhnyak, Andrew K. Ottens Jan 2015

Proteomics: In Pursuit Of Effective Traumatic Brain Injury Therapeutics, Pavel N. Lizhnyak, Andrew K. Ottens

Anatomy and Neurobiology Publications

Effective traumatic brain injury (TBI) therapeutics remain stubbornly elusive. Efforts in the field have been challenged by the heterogeneity of clinical TBI, with greater complexity among underlying molecular phenotypes than initially conceived. Future research must confront the multitude of factors comprising this heterogeneity, representing a big data challenge befitting the coming informatics age. Proteomics is poised to serve a central role in prescriptive therapeutic development, as it offers an efficient endpoint within which to assess post-TBI biochemistry. We examine rationale for multifactor TBI proteomic studies and the particular importance of temporal profiling in defining biochemical sequences and guiding therapeutic development. …


Post-Acute Brain Injury Urinary Signature: A New Resource For Molecular Diagnostics, Andrew K. Ottens, Jillian E. Stafflinger, Hailey E. Griffin, Richard D. Kunz, David X. Cifu, Janet P. Niemeier Jan 2014

Post-Acute Brain Injury Urinary Signature: A New Resource For Molecular Diagnostics, Andrew K. Ottens, Jillian E. Stafflinger, Hailey E. Griffin, Richard D. Kunz, David X. Cifu, Janet P. Niemeier

Anatomy and Neurobiology Publications

Heterogeneity within brain injury presents a challenge to the development of informative molecular diagnostics. Recent studies show progress particularly in cerebrospinal fluid with biomarker assays targeting one or a few structural proteins. Protein-based assays in peripheral fluids, however, have been more challenging to develop in part due to restricted and intermittent barrier access. Further, a greater number of molecular variables may be required to inform on patient status given the multifactorial nature of brain injury. Presented is an alternative approach profiling peripheral fluid for a class of small metabolic by-products rendered by ongoing brain pathobiology. Urine specimens were collected for …